デフォルト表紙
市場調査レポート
商品コード
1301109

吸入麻酔の市場規模、シェア、動向分析レポート:薬剤別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年

Inhalation Anesthesia Market Size, Share & Trends Analysis Report By Drug (Sevoflurane, Isoflurane, Desflurane), By Application, By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
吸入麻酔の市場規模、シェア、動向分析レポート:薬剤別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年
出版日: 2023年06月21日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

吸入麻酔市場の成長と動向

GrandView Research, Inc.の最新レポートによると、世界の吸入麻酔市場規模は2030年までに29億2,000万米ドルに達し、CAGR 9.04%を記録すると予測されています。

吸入麻酔薬は、他の選択肢と比較して、より優れた有効性とより少ない副作用とともに、より短い導入期間と回復時間を提供し、したがって、外科処置中に優れた麻酔効果を提供します。また、患者の麻酔時間のコントロールにも優れています。このような利点から、静脈麻酔よりも吸入麻酔が好まれています。

吸入麻酔で投与される薬剤は、静脈麻酔に比べて低用量でも作用発現が速いです。投与に吸入経路を用いることで、過剰投与が避けられ、患者の自律神経機能が損なわれないです。これらの薬剤は肺から排出されるため、体内に蓄積する可能性が低いです。したがって、肝毒性のリスクも低くなります。さらに、吸入経路で投与される薬剤は、他の代替経路に比べて耐性や中毒レベルが限られています。

AnaConDa(Anaesthetic Conserving Device)のような革新的な呼吸器製品の発売により、セボフルラン、イソフルランなどの吸入全身麻酔薬の投与が容易になっています。吸入麻酔は、患者の健康状態をモニターしやすくなるため、24時間以上人工呼吸をしている患者にとって最良の選択肢であると考えられています。

麻酔ガスに関する主な懸念は、患者が使用するのはわずか5%で、残りの95%は大気中に放出されるため、これらのガスが温室効果をもたらすことです。セボフルラン、イソフルラン、デスフルランを大気中の時間スパンと世界の大気中濃度に基づいて比較分析すると、デスフルランは環境に対して高い潜在的脅威をもたらすことがわかる。

吸入麻酔市場レポートハイライト

  • セボフルランは、その薬物動態学および薬力学が他の代替吸入麻酔薬よりも多くの利点をもたらすという事実により、2022年に最大の市場シェアを占めました。
  • デスフルランは、単独で、あるいは亜酸化窒素や他の吸入麻酔薬と組み合わせて、様々な外科手術に使用されます。
  • ハロタンには、ハロタン誘発性肝炎など多くの合併症が報告されているため、欧米諸国の大半ではこの麻酔薬の使用が中止されています。
  • 北米はセボフルランとデスフルランの需要が高いため、2022年の市場を独占しました。主要企業も様々な戦略的取り組みを行っており、それが米国での高い収益成長につながっています。
  • 中国はアジア太平洋最大の経済大国です。世界で最も人口の多い国であるため、手術のための患者数も多いです。大規模な患者プールの存在とともに、多くの手術が行われており、予測期間中に市場を押し上げると予想されます。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • セグメントの定義
  • 地域の範囲
  • 推定・予測のタイムライン
  • 目的
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • Gvrの内部データベース
    • 二次情報
    • 1次調査
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の形成と検証
  • モデル詳細
    • 商品フロー分析
  • 二次情報のリスト
  • 略語のリスト

第2章 エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 市場変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/アンシラリー市場見通し
  • 市場力学
    • 静脈麻酔と比較して高くなる患者の転帰
    • 病院医療費削減のニーズの高まり
    • 外科手術件数の増加
  • 市場抑制要因分析
    • 温室効果ガス排出に対する懸念の高まり
  • ポーターのファイブフォース分析
  • PESTLE分析
  • パイプライン分析

第4章 医薬品タイプのビジネス分析

  • 世界の吸入麻酔市場:医薬品変動分析
  • セボフルラン
  • デスフルラン
  • イソフルラン
  • その他

第5章 用途のビジネス分析

  • 世界の吸入麻酔市場:用途変動分析
  • 導入
  • 維持

第6章 最終用途のビジネス分析

  • 世界の吸入麻酔市場:最終使用の変動分析
  • 病院
  • 外来手術センター
  • その他

第7章 地域のビジネス分析

  • 地域別吸入麻酔市場シェア、2022年および2030年
  • 北米
    • 北米吸入麻酔市場、2018年~2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州吸入麻酔市場、2018年~2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋地域の吸入麻酔市場、2018年~2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの吸入麻酔市場、2018年~2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • MEA吸入麻酔市場、2018年~2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
    • 新製品の発売
    • パートナーシップ
    • 取得
    • コラボレーション
    • 資金調達
  • 主要企業の市場シェア分析、2022年
  • 企業ヒートマップ分析
  • 企業プロファイル
    • HALOCARBON PRODUCTS CORPORATION
    • BAXTER
    • ABBVIE INC
    • LUNAN PHARMACEUTICAL GROUP
    • PIRAMAL ENTERPRISES LTD
    • SANDOZ INTERNATIONAL GMBH
    • FRESENIUS KABI AG
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Incidence of Diseases
  • Table 4 Global Inhalation Anesthesia Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 6 Global Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global. Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 8 North America Inhalation Anesthesia Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 10 North America Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 13 U.S. Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 15 Canada Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 16 Canada Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 18 Europe Inhalation Anesthesia Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 20 Europe Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 22 Germany Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 23 Germany Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 25 UK Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 26 UK Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 UK Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 28 France Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 29 France Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 France Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 31 Italy Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 32 Italy Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Italy Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 34 Spain Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 35 Spain Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 37 Denmark Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 38 Denmark Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 40 Sweden Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 41 Sweden Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Sweden Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 43 Norway Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 44 Norway Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Inhalation Anesthesia Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 50 Japan Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 51 Japan Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 53 China Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 54 China Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 56 India Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 57 India Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 India Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 59 South Korea Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 60 South Korea Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 62 Australia Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 63 Australia Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Australia Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 65 Thailand Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 66 Thailand Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 68 Latin America Inhalation Anesthesia Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 70 Latin America Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 72 Brazil Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 73 Brazil Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Brazil Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 75 Mexico Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 76 Mexico Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Mexico Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 78 Argentina Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 79 Argentina Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Inhalation Anesthesia Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 88 South Africa Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 89 South Africa Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 South Africa Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 91 UAE Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 92 UAE Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Inhalation Anesthesia Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping
  • Fig. 15 Inhalation anesthesia market: drug outlook and key takeaways
  • Fig. 16 Inhalation anesthesia market: drug movement analysis & market share 2022 & 2030
  • Fig. 17 Sevoflurane market, 2018 - 2030 (USD Million)
  • Fig. 18 Desflurane market, 2018 - 2030 (USD Million)
  • Fig. 19 Isoflurane market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Inhalation anesthesia market: application outlook and key takeaways
  • Fig. 22 Inhalation anesthesia market: application movement analysis & market share 2022 & 2030
  • Fig. 23 Induction market, 2018 - 2030 (USD Million)
  • Fig. 24 Maintenance market, 2018 - 2030 (USD Million)
  • Fig. 25 Inhalation anesthesia market: end-use outlook and key takeaways
  • Fig. 26 Inhalation anesthesia market: end-use movement analysis & market share 2022 & 2030
  • Fig. 27 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 28 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional Marketplace: Key Takeaways
  • Fig. 31 Regional Outlook, 2022 & 2030
  • Fig. 32 Regional Market Dashboard
  • Fig. 33 Regional Market Place: Key Takeaways
  • Fig. 34 North America
  • Fig. 35 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 36 U.S.
  • Fig. 37 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Canada
  • Fig. 39 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Europe
  • Fig. 41 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 42 UK
  • Fig. 43 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Germany
  • Fig. 45 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 46 France
  • Fig. 47 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Italy
  • Fig. 49 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Spain
  • Fig. 51 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark
  • Fig. 53 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden
  • Fig. 55 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Norway
  • Fig. 57 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific
  • Fig. 59 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Japan
  • Fig. 61 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 62 China
  • Fig. 63 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 64 India
  • Fig. 65 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Australia
  • Fig. 67 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand
  • Fig. 69 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea
  • Fig. 71 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America
  • Fig. 73 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil
  • Fig. 75 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Mexico
  • Fig. 77 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Argentina
  • Fig. 79 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 80 MEA
  • Fig. 81 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 82 South Africa
  • Fig. 83 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Saudi Arabia
  • Fig. 85 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 86 UAE
  • Fig. 87 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Kuwait
  • Fig. 89 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Strategy Mapping
目次
Product Code: 978-1-68038-509-0

Inhalation Anesthesia Market Growth & Trends

The global inhalation anesthesia market size is expected to reach USD 2.92 billion by 2030, registering a CAGR of 9.04%, according to a new report by Grand View Research, Inc. Inhalation anesthetics offer shorter induction period and recovery time along with better efficacy and lesser adverse effects as compared to other alternatives, thus providing better anesthetic effect during surgical procedures. They also provide excellent control over the duration of anesthesia in the patient. Thus, inhalation anesthesia is being preferred over intravenous anesthesia due to these advantages.

Drugs administered through inhalation anesthesia have a quick onset of action even at low dose as compared to intravenous anesthesia. Using inhalation route for administration helps avoid excessive dosage and keeps the patient's autonomic functions intact. As these drugs are eliminated via lungs, they have lower chances of accumulation in the body. Hence, they result in lower risk of hepatotoxicity. In addition, drugs administered through inhalation route have limited tolerance and addiction level as compared to other alternatives routes.

With the launch of innovative respiratory products such as AnaConDa (Anaesthetic Conserving Device), administration of inhalation general anesthetic agents such as sevoflurane, isoflurane, & other agents have become easier. Inhalation anesthesia is considered to be the best alternative for patients who are on ventilation for more than 24 hours as it becomes easy to monitor the patient's health.

Major concern associated with anesthetic gas is that only 5% account for patient use and the rest 95% is released in the atmosphere, which leads to greenhouse effect of these gases. The comparative analysis of sevoflurane, isoflurane, and desflurane based on atmospheric time span and global atmospheric concentrations indicates that desflurane poses a high potential threat for environment.

Inhalation Anesthesia Market Report Highlights

  • Sevoflurane held the largest market share in 2022, due to the fact that its pharmacokinetics and pharmacodynamics leads to many advantages over other alternate inhaled anesthetic agents available.
  • Desflurane, alone or in combination with nitrous oxide or other inhalation anesthetic agents is used in various surgical procedures owing to its rapid onset of action and elimination rate; therefore, driving the segment demand.
  • There have been many complications reported with halothane, for instance, halothane-induced hepatitis; therefore, this anesthetic agent has been discontinued in the majority of the western countries.
  • North America dominated the market in 2022 due to the high demand for sevoflurane and desflurane in the region. Key companies are also undertaking various strategic initiatives that has led to their high revenue growth in the U.S.
  • China is the largest economy in Asia Pacific. It is a country with the maximum population in the world, hence having a large patient pool for surgeries. A large number of surgeries being performed along with the presence of a large patient pool is anticipated to boost the market over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Test Segment
      • 1.1.1.2 Service Provider Segment
      • 1.1.1.3 Application Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Higher patient outcome as compared to intravenous anesthesia.
    • 3.3.2. Increasing need to reduce hospital care cost
    • 3.3.3. Rising number of surgical procedures
  • 3.4. Market restraint analysis
    • 3.4.1. Increasing concern about greenhouse gas emissions
  • 3.5. Porter's Five Forces Analysis
  • 3.6. PESTLE Analysis
  • 3.7. Pipeline Analysis

Chapter 4. Drug Type Business Analysis

  • 4.1. Global Inhalation Anesthesia Market: Drug Movement Analysis
  • 4.2. Sevoflurane
    • 4.2.1. Sevoflurane market estimates and forecasts, 2018 - 2030 (USD million)
  • 4.3. Desflurane
    • 4.3.1. Desflurane market estimates and forecasts, 2018 - 2030 (USD million)
  • 4.4. Isoflurane
    • 4.4.1. Isoflurane market estimates and forecasts, 2018 - 2030 (USD million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts, 2018 - 2030 (USD million)

Chapter 5. Application Business Analysis

  • 5.1. Global Inhalation Anesthesia Market: Application Movement Analysis
  • 5.2. Induction
    • 5.2.1. Induction market estimates and forecasts, 2018 - 2030 (USD million)
  • 5.3. Maintenance
    • 5.3.1. Maintenance estimates and forecasts, 2018 - 2030 (USD million)

Chapter 6. End-use Business Analysis

  • 6.1. Global Inhalation Anesthesia Market: End-use Movement Analysis
  • 6.2. Hospitals
    • 6.2.1. S Hospitals market estimates and forecasts, 2018 - 2030 (USD million)
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD million)
  • 6.4. Others
    • 6.4.1. Others market estimates and forecasts, 2018 - 2030 (USD million)

Chapter 7. Regional Business Analysis

  • 7.1. Inhalation Anesthesia Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. Reimbursement Scenario
      • 7.2.2.6. U.S. Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. Canada Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. Reimbursement Scenario
      • 7.3.2.6. Germany Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. UK Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. France Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. Italy Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Spain Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Denmark Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Sweden Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Norway Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Reimbursement Scenario
      • 7.4.2.6. Japan Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. China Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. India Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. South Korea Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Australia Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Thailand Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Reimbursement Scenario
      • 7.5.2.6. Brazil Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Mexico Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Argentina Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Reimbursement Scenario
      • 7.6.2.6. South Africa Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. Saudi Arabia Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. UAE Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. Kuwait Inhalation Anesthesia Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2022
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. HALOCARBON PRODUCTS CORPORATION
      • 8.5.1.1. Company Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. BAXTER
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. ABBVIE INC
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. LUNAN PHARMACEUTICAL GROUP
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. PIRAMAL ENTERPRISES LTD
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. SANDOZ INTERNATIONAL GMBH
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. FRESENIUS KABI AG
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives